Non–Small Cell Lung Cancer, Version 2.2013

View More View Less
  • 1 From The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Huntsman Cancer Institute at the University of Utah; Fox Chase Cancer Center; University of Michigan Comprehensive Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; City of Hope Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Memorial Sloan-Kettering Cancer Center; UNMC Eppley Cancer Center at The Nebraska Medical Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Moffitt Cancer Center; University of Tennessee Cancer Institute; and National Comprehensive Cancer Network.
Restricted access

These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer. The NCCN Guidelines Insights focus on the major updates in the NCCN Guidelines and discuss the new updates in greater detail.

Supplementary Materials

    • Supplemental Material (PDF 410 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1389 565 45
PDF Downloads 263 129 12
EPUB Downloads 0 0 0